Fresenius Kabi iPSUM, a unit of the Fresenius Kabi group, applies current Best Manufacturing Practices (BMP) in its specialist manufacturing of β-lactam type active principles, for oral and sterile formulations. Approved by the FDA (Food and Drug Administration), it supplies third parties with its products that include penicillins and sterile cephalosporins such as: tazobactam, ceftriaxone, cefuroxime, cefazolin, cefotaxime, ceftazidime and also in association with sulbactam, amoxicillin, cloxacillin, dicloxacillin, flucloxacillin, nafcillin, oxacillin, mecillinam, and various associations of penicillins.
FRESENIUS KABI IPSUM
činnost
Klíčová slova spojená s tímto podnikem
- Farmaceutické výrobky
- ANTI-INFECTIVES
- AMOXICILLIN
- active pharmaceutical ingredients
- CEFALONIUM
- CLOXACILLIN
- AMPICILLIN
- sterile cephalosporins
- CEFEPIME
- chemical products for the pharmaceutical industry
Zvětšit seznam
Další informace
Klíčové ukazatele
Organizace
Trhy a obchodovací oblasti
Obchodní informace
A32661920
3183 v